ANTI NMDA RECEPTOR ENCEPHALITIS IGG ANTIBODIES - SERUM

The Anti-NMDA Receptor Encephalitis IgG Antibodies (Serum) Test is a specialized blood test used to detect IgG antibodies against the N-Methyl-D-Aspartate (NMDA) receptor, a critical receptor involved in brain signaling, memory, learning, and normal neurological function. These antibodies are strongly associated with Anti-NMDA Receptor Encephalitis, a potentially serious but treatable autoimmune disorder in which the immune system mistakenly attacks NMDA receptors in the brain.

Patients with Anti-NMDA Receptor Encephalitis may develop a combination of psychiatric symptoms, seizures, memory impairment, confusion, speech disturbances, abnormal movements, and reduced consciousness. Early diagnosis is essential because prompt immunotherapy and treatment of any underlying cause, such as certain tumors, can significantly improve outcomes.

Although cerebrospinal fluid (CSF) antibody testing is generally more sensitive, serum testing provides valuable diagnostic information and is commonly performed as part of the evaluation for suspected autoimmune encephalitis.

Benefits of the Test

• Detects Anti-NMDA Receptor IgG antibodies in serum.
• Helps diagnose autoimmune encephalitis.
• Supports early identification of neurological autoimmune disorders.
• Assists in evaluating unexplained psychiatric and neurological symptoms.
• Helps guide immunotherapy and further neurological investigations.
• Supports monitoring alongside clinical assessment and other laboratory tests.

Why Doctors Recommend This Test

Doctors may recommend the Anti-NMDA Receptor Encephalitis IgG Antibodies (Serum) Test for individuals with symptoms such as:

• Sudden behavioral or personality changes
• New-onset psychosis or hallucinations
• Memory loss
• Seizures
• Confusion or altered mental status
• Difficulty speaking or understanding language
• Involuntary movements or muscle rigidity
• Reduced consciousness
• Unexplained neurological deterioration

The test is frequently ordered along with CSF Anti-NMDA Receptor Antibody testing, MRI Brain, Electroencephalogram (EEG), CSF analysis, autoimmune encephalitis antibody panels, and other neurological investigations.

Preparation Before Test

• No fasting is required.
• Continue routine medications unless advised otherwise by your physician.
• Inform your healthcare provider about neurological symptoms, autoimmune disorders, recent infections, or current medications.
• A blood sample is collected for laboratory analysis.

Normal Reporting Time

Reporting Time: Usually 5–10 working days, depending on laboratory processing protocols.

Who Should Take This Test?

This test is recommended for:

• Individuals with suspected autoimmune encephalitis.
• Patients with unexplained seizures or encephalopathy.
• Individuals with sudden psychiatric symptoms and neurological abnormalities.
• Patients with suspected paraneoplastic neurological syndromes.
• Individuals referred by neurologists or psychiatrists for autoimmune evaluation.

Patient-Friendly Summary

The Anti-NMDA Receptor Encephalitis IgG Antibodies (Serum) Test is a blood test that checks for antibodies directed against NMDA receptors in the brain. These antibodies can cause Anti-NMDA Receptor Encephalitis, an autoimmune condition that affects brain function. Symptoms may include sudden personality changes, confusion, hallucinations, seizures, abnormal body movements, memory problems, or difficulty speaking. Early diagnosis is important because this condition is often treatable with appropriate medical care. While testing of cerebrospinal fluid (CSF) is often recommended for confirmation, the serum test provides important diagnostic information and helps doctors evaluate suspected autoimmune encephalitis. The test is safe, requires only a blood sample, and generally does not require fasting.